ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,496Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 1185

$1.19M Total Retail Price of All Prescriptions

Rank: 25 out of 1185

667 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 667 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 667 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 18,244 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
AMLODIPINE BESYLATE 795 643 1 1
FUROSEMIDE 758 650 2 8
OMEPRAZOLE 744 581 3 6
PRAVASTATIN SODIUM 637 439 4 7
SIMVASTATIN 584 461 5 5
METOPROLOL TARTRATE 572 430 6 10
LEVOTHYROXINE SODIUM 548 447 7 3
POTASSIUM CHLORIDE 539 438 8 18
GABAPENTIN 511 362 9 13
METFORMIN HCL 499 320 10 9
LISINOPRIL 451 341 11 4
HYDROCODONE-ACETAMINOPHEN 447 306 S3 12 2
HYDROCHLOROTHIAZIDE 388 323 13 12
RANITIDINE HCL 362 299 14 17
BENAZEPRIL HCL 329 244 15 41
TRAMADOL HCL 325 279 16 16
METOPROLOL SUCCINATE 321 285 17 20
DONEPEZIL HCL 307 263 18 32
NEXIUM 302 210 19 19
WARFARIN SODIUM 263 193 20 21
ATORVASTATIN CALCIUM 258 186 21 11
TRAZODONE HCL 256 215 22 38
CLOPIDOGREL 254 198 23 31
FLUTICASONE PROPIONATE 252 190 24 29
CLONIDINE HCL 251 142 25 47
CARVEDILOL 224 193 26 24
CITALOPRAM HBR 198 172 27 22
METFORMIN HCL ER 197 158 28 35
SINGLE USE SWAB 187 174 29 178
MIRTAZAPINE 181 177 30 57
ALLOPURINOL 177 144 31 30
ISOSORBIDE MONONITRATE ER 175 153 32 48
AMLODIPINE BESYLATE-BENAZEPRIL 171 134 33 42
LEVEMIR FLEXPEN 163 138 34 129
PEN NEEDLE 159 109 35 139
CYCLOBENZAPRINE HCL 156 85 R 36 53
LISINOPRIL-HYDROCHLOROTHIAZIDE 155 128 37 14
SERTRALINE HCL 143 80 38 25
LEVETIRACETAM 141 123 39 131
ADVAIR DISKUS 139 84 40 54
TAMSULOSIN HCL 136 105 41 34
PLAVIX 131 105 42 45
CARBIDOPA-LEVODOPA 131 131 42 142
ENALAPRIL MALEATE 127 76 44 65
NOVOFINE AUTOCOVER 126 117 45 236
ZETIA 124 93 46 78
JANUVIA 121 93 47 68
PAROXETINE HCL 119 65 48 73
VENLAFAXINE HCL ER 119 66 48 105
NOVOLOG FLEXPEN 117 99 50 157
ACTOS 117 85 50 86
DIOVAN HCT 114 89 52 46
DIOVAN 110 92 53 37
BACLOFEN 109 37 54 150
DIGOXIN 108 82 55 67
DOXAZOSIN MESYLATE 106 95 56 84
CYMBALTA 102 48 57 44
GLIPIZIDE 102 83 57 56
ALENDRONATE SODIUM 100 98 59 40
POLYETHYLENE GLYCOL 3350 99 89 60 60
LOSARTAN POTASSIUM 99 89 60 26
PANTOPRAZOLE SODIUM 98 74 62 58
SULFAMETHOXAZOLE-TRIMETHOPRIM 97 70 63 91
CRESTOR 96 71 64 23
NAMENDA 96 96 64 43
KLOR-CON M20 96 69 64 59
ZOLPIDEM TARTRATE 95 71 67 15
FINASTERIDE 94 84 68 132
RISPERIDONE 93 81 69 72
SPIRIVA 91 65 70 64
SPIRONOLACTONE 88 65 71 75
HYDRALAZINE HCL 86 65 72 112
GLIPIZIDE XL 79 54 73 95
PREDNISONE 75 66 74 33
MONTELUKAST SODIUM 74 64 75 186
GLYBURIDE-METFORMIN HCL 74 72 R 75 88
ATENOLOL 72 47 77 28
DICLOFENAC SODIUM 72 49 77 81
RAMIPRIL 72 58 77 135
ENDOCET 71 28 S2 80 80
KLOR-CON 10 71 57 80 118
COLCRYS 70 65 82 110
DILTIAZEM 24HR CD 70 70 82 123
NITROGLYCERIN PATCH 70 70 82 202
SINGULAIR 70 54 82 106
PROMETHAZINE HCL 69 52 R 86 76
SYMBICORT 69 39 86 144
KLOR-CON M10 68 60 88 141
LANTUS 68 43 88 66
PROAIR HFA 66 34 90 50
OXYCODONE HCL-ACETAMINOPHEN 66 30 S2 90 82
FENOFIBRATE 64 48 92 55
METOCLOPRAMIDE HCL 64 45 92 134
ROPINIROLE HCL 62 55 94 108
RIVASTIGMINE 61 29 95 282
AZITHROMYCIN 60 41 96 39
TRIAMCINOLONE ACETONIDE 58 48 97 130
LIPITOR 58 36 97 89
IBUPROFEN 57 38 99 102
GLYBURIDE 57 42 R 99 100
VALPROIC ACID 56 42 101 213
GLIMEPIRIDE 56 48 101 49
GEMFIBROZIL 55 39 103 119
NITROSTAT 55 49 103 196
NAPROXEN 54 21 105 92
AMITRIPTYLINE HCL 54 49 R 105 51
CILOSTAZOL 53 53 107 222
NIFEDIPINE ER 52 47 108 97
PHENYTOIN SODIUM EXTENDED 51 0 109 111
ISOSORBIDE DINITRATE 51 51 109 310
NOVOLOG MIX 70-30 FLEXPEN 50 48 111 203
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 26, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.